Tiaa, Fsb Gilead Sciences, Inc. Transaction History

Tiaa, Fsb

$27.6 Billion
Q2 2023

A detailed history of Tiaa, Fsb transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Tiaa, Fsb holds 37,616 shares of GILD stock, worth $3.48 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

37,616

Previous 40,564 7.27%

Holding current value

$3.48 Million

Previous $3.37 Million 13.85%

% of portfolio

0.01%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	SELL	$76.01 - $86.7 $224,077 - $255,591	-2,948 Reduced 7.27%	37,616 $2.9 Million
Q1 2023 Apr 19, 2023	SELL	$77.31 - $88.08 $712,102 - $811,304	-9,211 Reduced 18.51%	40,564 $3.37 Million
Q4 2022 Jan 12, 2023	SELL	$62.32 - $89.47 $10.2 Million - $14.7 Million	-164,417 Reduced 76.76%	49,775 $4.27 Million
Q3 2022 Oct 11, 2022	SELL	$59.54 - $68.01 $360,931 - $412,276	-6,062 Reduced 2.75%	214,192 $13.2 Million
Q2 2022 Aug 09, 2022	BUY	$57.72 - $65.01 $10.6 Million - $11.9 Million	183,732 Added 503.07%	220,254 $13.6 Million
Q1 2022 Apr 13, 2022	SELL	$57.92 - $72.58 $75,759 - $94,934	-1,308 Reduced 3.46%	36,522 $2.14 Million
Q4 2021 Feb 01, 2022	SELL	$64.88 - $73.64 $275,675 - $312,896	-4,249 Reduced 10.1%	37,830 $2.71 Million
Q3 2021 Oct 14, 2021	BUY	$67.69 - $73.03 $145,939 - $157,452	2,156 Added 5.4%	42,079 $2.94 Million
Q2 2021 Jul 21, 2021	BUY	$63.47 - $69.35 $51,664 - $56,450	814 Added 2.08%	39,923 $2.75 Million
Q1 2021 Apr 21, 2021	BUY	$60.0 - $68.46 $21,240 - $24,234	354 Added 0.91%	39,109 $2.53 Million
Q4 2020 Jan 21, 2021	SELL	$56.65 - $64.55 $11,499 - $13,103	-203 Reduced 0.52%	38,755 $2.26 Million
Q3 2020 Oct 13, 2020	BUY	$62.1 - $78.08 $91,970 - $115,636	1,481 Added 3.95%	38,958 $2.46 Million
Q2 2020 Jul 15, 2020	BUY	$72.34 - $84.0 $83,335 - $96,768	1,152 Added 3.17%	37,477 $2.88 Million
Q1 2020 Apr 21, 2020	SELL	$62.63 - $80.22 $100,896 - $129,234	-1,611 Reduced 4.25%	36,325 $2.72 Million
Q4 2019 Jan 13, 2020	BUY	$61.62 - $67.78 $54,595 - $60,053	886 Added 2.39%	37,936 $2.47 Million
Q3 2019 Oct 08, 2019	SELL	$62.51 - $69.0 $179,028 - $197,616	-2,864 Reduced 7.18%	37,050 $2.35 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $5.95 Million - $6.67 Million	-96,209 Reduced 70.68%	39,914 $2.7 Million
Q1 2019 Apr 15, 2019	SELL	$62.53 - $70.05 $741,480 - $830,652	-11,858 Reduced 8.01%	136,123 $8.85 Million
Q4 2018 Apr 15, 2019	BUY	$60.54 - $79.0 $8.96 Million - $11.7 Million	147,981 New	147,981 $9.26 Million
Q4 2018 Feb 22, 2019	SELL	$60.54 - $79.0 $6.94 Million - $9.06 Million	-114,672 Closed	0 $0
Q3 2018 Oct 18, 2018	BUY	$71.28 - $78.92 $5.23 Million - $5.79 Million	73,404 Added 177.87%	114,672 $8.85 Million
Q2 2018 Jul 20, 2018	BUY	$64.88 - $75.68 $34,775 - $40,564	536 Added 1.32%	41,268 $2.92 Million
Q1 2018 Apr 18, 2018	SELL	$72.84 - $88.8 $186,106 - $226,884	-2,555 Reduced 5.9%	40,732 $3.07 Million
Q4 2017 Jan 29, 2018	SELL	$71.15 - $83.52 $323,305 - $379,514	-4,544 Reduced 9.5%	43,287 $3.1 Million
Q3 2017 Oct 24, 2017	BUY	$72.11 - $85.47 $3.45 Million - $4.09 Million	47,831	47,831 $3.88 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tiaa, Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Tiaa, Fsb with notifications on news.

Account